| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |